We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+5.86%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$3.39B
AUM Growth
-$3.22M
(-0.09%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-3.57%
Top 10 Holdings %
Top 10 Hldgs %
13.53%
Holding
1,471
New
480
Increased
247
Reduced
250
Closed
489
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$46.4M |
| 2 |
Starbucks
SBUX
|
+$45M |
| 3 |
Boeing
BA
|
+$43.3M |
| 4 |
Medtronic
MDT
|
+$37.9M |
| 5 |
Pfizer
PFE
|
+$37.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$54.8M |
| 2 |
Wells Fargo
WFC
|
+$37.8M |
| 3 |
Caterpillar
CAT
|
+$37.8M |
| 4 |
Union Pacific
UNP
|
+$36.6M |
| 5 |
MetLife
MET
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.36% |
| 2 | Healthcare | 12% |
| 3 | Industrials | 11.97% |
| 4 | Technology | 9.55% |
| 5 | Consumer Staples | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Harte-Hanks
HHS
$16.1M
| $173K | 0.01% |
2,207
+292
| +15% | +$23.8K |
|
927
United Microelectronic
UMC
$43.1B
| $172K | 0.01% |
84,378
-48,327
| -36% | -$97.9K |
|
928
Eldorado Gold
EGO
$8.14B
| $169K | 0.01% |
5,951
-88,265
| -94% | -$2.71M |
|
|
FBR
929
DELISTED
Fibria Celulose Sa
FBR
| $168K | 0.01% |
14,344
-3,859
| -21% | -$47.5K |
|
|
YZC
930
DELISTED
Yanzhou Coal Mining
YZC
| $166K | ﹤0.01% |
+17,969
| New | +$179K |
|
|
HRG
931
DELISTED
HRG Group, Inc.
HRG
| $166K | ﹤0.01% |
14,011
+1,538
| +12% | +$17K |
|
932
Compugen
CGEN
$212M
| $163K | ﹤0.01% |
+18,253
| New | +$178K |
|
933
Mueller Water Products
MWA
$3.96B
| $159K | ﹤0.01% |
16,994
-48,862
| -74% | -$417K |
|
934
Skywest
SKYW
$4.44B
| $159K | ﹤0.01% |
+10,690
| New | +$163K |
|
|
SGYP
935
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $159K | ﹤0.01% |
28,661
-20,134
| -41% | -$86.8K |
|
|
ONE
936
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $153K | ﹤0.01% |
15,673
-6,688
| -30% | -$60.5K |
|
937
Photronics
PLAB
$1.66B
| $151K | ﹤0.01% |
16,777
-3,009
| -15% | -$25.4K |
|
|
OME
938
DELISTED
Omega Protein
OME
| $149K | ﹤0.01% |
+12,112
| New | +$142K |
|
939
Novavax
NVAX
$1.2B
| $148K | ﹤0.01% |
+1,445
| New | +$102K |
|
940
Talphera
TLPH
$67M
| $148K | ﹤0.01% |
653
-99
| -13% | -$17.2K |
|
941
TTM Technologies
TTMI
$10.7B
| $148K | ﹤0.01% |
17,254
+450
| +3% | +$4.15K |
|
|
PDLI
942
DELISTED
PDL BioPharma, Inc.
PDLI
| $148K | ﹤0.01% |
+17,523
| New | +$148K |
|
|
BRCD
943
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $146K | ﹤0.01% |
+16,500
| New | +$138K |
|
|
SMA
944
DELISTED
SYMMETRY MEDICAL INC
SMA
| $143K | ﹤0.01% |
14,170
-5,203
| -27% | -$45.3K |
|
|
JCP
945
DELISTED
J.C. Penney Company, Inc.
JCP
| $142K | ﹤0.01% |
15,480
-90,853
| -85% | -$758K |
|
|
IIP
946
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $142K | ﹤0.01% |
18,916
-3,479
| -16% | -$26.1K |
|
947
Boyd Gaming
BYD
$6.74B
| $141K | ﹤0.01% |
+12,512
| New | +$148K |
|
|
SCLN
948
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $140K | ﹤0.01% |
27,854
+4,161
| +18% | +$20K |
|
949
Geron
GERN
$905M
| $137K | ﹤0.01% |
+30,568
| New | +$131K |
|
|
OREX
950
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $137K | ﹤0.01% |
2,430
-8,095
| -77% | -$455K |
|
Similar funds
CCA
GAMA
TWP
ACA
CAAM
RK
PCM
ITC
Stevens Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Stevens Capital Management held 1,471 positions worth $3.39B, down 0.09% from $3.39B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Stevens Capital Management withdrew a net $121M in Q4 2013, closing 489 positions and reducing 250 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $54.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in PepsiCo worth $46.3M.
- Stevens Capital Management's largest Q4 2013 buy was PepsiCo: 558,634 shares worth $46.3M.
- Stevens Capital Management added most to Pfizer in Q4 2013, an estimated $37.5M increase.
- Stevens Capital Management's biggest Q4 2013 reduction was Wells Fargo, cutting an estimated $37.8M.
- Stevens Capital Management fully exited Alphabet (Google) Class C in Q4 2013, selling an estimated $54.8M.
- Stevens Capital Management's ten largest holdings make up 14% of its $3.39B portfolio in Q4 2013.
- Stevens Capital Management opened 480 new positions and closed 489 in Q4 2013.
- Stevens Capital Management's portfolio value fell 0.09% quarter-over-quarter to $3.39B.
Based on Stevens Capital Management's 13F filing for Q4 2013, filed 6 Feb 2014.